MODD vs. INFU, SGHT, NVRO, PDEX, TLSI, ZJYL, TELA, SRTS, ECOR, and FONR
Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include InfuSystem (INFU), Sight Sciences (SGHT), Nevro (NVRO), Pro-Dex (PDEX), TriSalus Life Sciences (TLSI), Jin Medical International (ZJYL), TELA Bio (TELA), Sensus Healthcare (SRTS), electroCore (ECOR), and FONAR (FONR). These companies are all part of the "medical equipment" industry.
Modular Medical vs.
InfuSystem (NYSE:INFU) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.
71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 10.2% of InfuSystem shares are owned by insiders. Comparatively, 32.3% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, InfuSystem had 1 more articles in the media than Modular Medical. MarketBeat recorded 1 mentions for InfuSystem and 0 mentions for Modular Medical. InfuSystem's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.
InfuSystem has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500.
InfuSystem has a net margin of 1.12% compared to Modular Medical's net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Modular Medical's return on equity.
InfuSystem received 4 more outperform votes than Modular Medical when rated by MarketBeat users.
InfuSystem currently has a consensus target price of $13.00, suggesting a potential upside of 62.91%. Modular Medical has a consensus target price of $5.00, suggesting a potential upside of 313.22%. Given Modular Medical's higher possible upside, analysts clearly believe Modular Medical is more favorable than InfuSystem.
InfuSystem has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.
Summary
InfuSystem beats Modular Medical on 12 of the 15 factors compared between the two stocks.
Get Modular Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Modular Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MODD) was last updated on 1/21/2025 by MarketBeat.com Staff
